Prior to joining ChemDiv, Dr. Savchuk held various business and research management positions in the IT industry with companies in Singapore and Russia. Since joining the company he has held positions of increasing responsibility including Director of Information Technologies, and Director and Vice President of Business Development. Dr. Savchuk has a PhD in Physics and Mathematics from Moscow Institute of Physics and Technology. He is the author of over 60 scientific papers.
ALEXANDER IVACHTCHENKO, Prof., DSc.
Chief Scientific Officer, Founder
Dr. Ivashchenko holds Doctor of Sciences (1982) and Professor (1988) degrees. He is the Distinguished Inventor of the Russian Federation (1984), the winner of the State Prize of the USSR (1983) and the Prize of the Council of Ministers of the USSR (1989).Dr. Ivashchenko is a world-recognized expert in the field of medicinal chemistry. He has been instrumental in advancing and supervising a series of studies on the development of innovative drugs for the treatment of cancer, hepatitis C, influenza, Alzheimer’s disease, schizophrenia and obesity. Many of these studies are currently at the clinical stage. Dr. Ivashchenko is a co-author of over 750 scientific publications and patents.Alex V. Ivashchenko (born March 24, 1945) is a founder and CSO of Chemical Diversity Research Institute (CDRI) of the Center of High Technologies “ChemRar” (Khimki, Moscow region), ChemDiv Inc. (USA), AllaChem LLC (USA), Avineuro Pharmaceuticals (USA).
RONALD DEMUTH, B.S., C.R.A. Senior VP, Corporate Development & General Manager
Prior to joining ChemDiv, Mr. Demuth held the positions of General Manager at Integrated Genomics. He has a long track record in the management of new ventures including holding the position of CEO of Cerulean Enterprises. Mr. Demuth has a BSc in Psychology from the University of Iowa and was a co-founder of the internationally-recognized Chicago Teacher Academy for Mathematics and Science with the Nobel Laureate Physicist, Leon Lederman. He is the author of 13 scientific papers.
Dmitry Kravchenko, Ph.D. General Director of JSC Chemical Diversity Research Institute
Dmitry Kravchenko was born on July 2, 1972 in the village of Rodniki, Moscow region.
In 1995 he graduated with honors from the Chemical Engineering Department of the Mendeleev Chemical Technology University where he specialized in Chemical technology of synthetic biologically active substances.
From March 1995 to March 1999 he worked as a researcher, then senior researcher in the Immunomodulators laboratory at the Gerontology Research Institute of the Ministry of Health of the Russian Federation. In 1996 he was an intern at the US Marshall State University, Minnesota.
From June 1999 to March 2003 Dr. Kravchenko was Head of the Organic Synthesis Department at Contact Service LLC.
Since March 2003 he has held the position of General Director of JSC Chemical Diversity Research Institute – a member of the ChemRar High-Tech Center with over 200 employees engaged in research and development in the field of pharmacology.
In 1998, Dr. Kravchenko successfully defended his thesis, and in 2006 he received a PhD in Chemistry. He has over 80 scientific papers and inventions, of which 11 are patented.
VADIM BICHKO, Ph.D. Vice President and Head, Infectious Diseases
Dr. Bichko is a virologist with 15 years of successful research and development management experience in pharmaceutical and biotechnology companies. Prior to joining ChemDiv, he was Director of Research at Idenix Pharmaceuticals, a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human viral infectious diseases. Prior to that, he was a leading virology researcher at Scriptgen (Anadys) Pharmaceuticals and previously held various academic positions at Fox Chase Cancer Center in Philadelphia, Max-Plank Institute for Biochemistry in Munich, Germany and the Institute of Organic Synthesis in Riga, Latvia. Dr. Bichko has a Ph.D. in molecular biology from the University of Latvia in Riga, Latvia. He is the author of numerous publications and patents in molecular virology.
ALEXANDER KHVAT, Ph.D. Senior Director of Research & Development
Prior to joining ChemDiv, Dr. Khvat held the positions of Senior Research Scientist at the Ukrainian Scientific Research Institute for Pharmacology and Therapy of Endocrine Disorders and Post-Doctoral Research Scientist at the University of Nottingham, UK. He has a nine year track-record in custom synthesis and spectroscopic investigations of organic compounds including completion of over fifty custom and medicinal chemistry projects with major pharmaceutical and biotech companies. Dr. Khvat has a Ph.D. in organic chemistry from Kharkov State University and is the author of 26 scientific papers and 20 patents.